Sensus Healthcare, Inc. (SRTS) Stock Forecast
SRTS analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.75 / 5 from 4 analysts
- Price target
- $5.38 average of analyst targets
- Upside to target
- +94.0% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $-0.04
- 52-week range
- $2.69 – $5.30
SRTS analyst ratings
4 analystsNumber of analysts at each rating.
SRTS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SRTS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.04 | −$0.08 | $0.02 | −$0.06 | +27.8% | 3 |
| Current fiscal year (2026) | −$0.76 | −$0.82 | −$0.66 | −$0.47 | −61.7% | 3 |
| Next fiscal year (2027) | −$0.17 | −$0.31 | −$0.06 | −$0.76 | +77.2% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SRTS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $6.6M | $5.4M | $8.5M | −3.9% | 4 |
| Current fiscal year (2026) | $19.1M | $16.6M | $22.0M | −30.4% | 4 |
| Next fiscal year (2027) | $28.2M | $24.8M | $31.3M | +47.3% | 4 |
SRTS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SRTS revenue: reported and forecast
SRTS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.05 | −$0.05 | −$0.06 | −$0.06 | −$0.04 | −7.3% | 0 up · 0 down |
| Current fiscal year (2026) | −$0.29 | −$0.29 | −$0.33 | −$0.33 | −$0.76 | +159.1% | 0 up · 0 down |
| Next fiscal year (2027) | −$0.02 | −$0.02 | −$0.09 | −$0.09 | −$0.17 | +937.7% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SRTS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SRTS beat in 5 of 12.
What analysts expect from SRTS
4 analysts cover Sensus Healthcare; their consensus rating is strong buy (4.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $5.38, 94.0% above the latest close of $2.77. Analysts expect earnings of −$0.76 per share for 2026, −61.7% from a year earlier. For 2027 the average estimate is −$0.17 per share on revenue of $28.2 million. Sensus Healthcare beat the EPS estimate in 5 of the last 12 quarters.
Related: SRTS income statement, SRTS key metrics, SRTS chart. See the SRTS stock overview for the latest quote and news.
SRTS forecast FAQ
What is Sensus Healthcare's price target?
The average analyst price target for Sensus Healthcare is $5.38, 94.0% above the latest close of $2.77.
Is Sensus Healthcare a buy, hold or sell?
Of 4 analysts covering Sensus Healthcare, 3 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Sensus Healthcare's EPS forecast?
Analysts forecast −$0.76 per share for 2026 (range −$0.82 to −$0.66); for 2027 the estimate is −$0.17.
What is Sensus Healthcare's revenue forecast?
The average revenue estimate for 2026 is $19.1 million, growth of −30.4%; for 2027 it is $28.2 million.
When does Sensus Healthcare report earnings?
Sensus Healthcare is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $-0.04.
Does Sensus Healthcare usually beat earnings estimates?
Sensus Healthcare reported EPS at or above the analyst estimate in 5 of the last 12 quarters.